Here's What You May Have Missed About ABEV

More and more people are talking about Ambev over the last few weeks. Is it worth buying the Alcoholic Beverages stock at a price of $2.97? Only time will tell. The information below will give you a basic idea of what this investment may entail:

  • Ambev has moved -4.8% over the last year, and the S&P 500 logged a change of -14.7%

  • ABEV has an average analyst rating of hold and is -11.61% away from its mean target price of $3.36 per share

  • Its trailing earnings per share (Eps) is $0.15

  • Ambev has a trailing 12 month Price to Earnings (P/E) ratio of 19.8 while the S&P 500 average is 15.97

  • Its forward earnings per share (Eps) is $0.15 and its forward P/E ratio is 19.8

  • The company has a Price to Book (P/B) ratio of 0.5 in contrast to the S&P 500's average ratio of 2.95

  • Ambev is part of the Consumer Defensive sector, which has an average P/E ratio of 24.21 and an average P/B of 4.09

  • ABEV has reported YOY quarterly earnings growth of -12.5% and gross profit margins of 49.5%

  • The company has a free cash flow of $7,670,272,512.00, which refers to the total sum of all its inflows and outflows of cash over the last quarter

  • Ambev S.A., through its subsidiaries, produces, distributes, and sells beer, draft beer, carbonated soft drinks, other non-alcoholic beverages, malt, and food products. The company was founded in 1885 and is headquartered in São Paulo, Brazil. Ambev S.A. is a subsidiary of Interbrew International B.V.

At Market Interference, our goal is to help educate investors about headline-making stocks. We believe informed investment decisions are good investment decisions. subscribe to our free newsletter to stay on top of each day's market movements!

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.